Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes

Luca Boeri, Matteo Soligo, Igor Frank, Stephen A. Boorjian, R. Houston Thompson, Matthew Tollefson, Fernando J. Quevedo, John C. Cheville, R. Jeffrey Karnes

Research output: Contribution to journalArticlepeer-review

20 Scopus citations

Abstract

Prolonged time to cystectomy (TTC) after neoadjuvant chemotherapy was associated with adverse survival in bladder cancer patients. Patients with higher rates of comorbidities were more likely to have prolonged TTC. Attempts should be made to shorten TTC after preoperative chemotherapy.

Original languageEnglish (US)
Pages (from-to)390-396
Number of pages7
JournalEuropean Urology Oncology
Volume2
Issue number4
DOIs
StatePublished - Jul 2019

Keywords

  • Bladder cancer
  • Neoadjuvant chemotherapy
  • Radical cystectomy
  • Risk factors
  • Surgery delay

ASJC Scopus subject areas

  • Surgery
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Urology

Fingerprint Dive into the research topics of 'Delaying Radical Cystectomy After Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer is Associated with Adverse Survival Outcomes'. Together they form a unique fingerprint.

Cite this